SCHEMBL145510

SCHEMBL145510

NC(=O)c1c(N)cccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
JAK1 P23458 1/20 0.51
TSHR P16473 3/20 0.46
NR4A2 P43354 1/20 0.45
P2RX7 Q99572 1/20 0.44
PBRM1 Q86U86 1/20 0.44
POLB P06746 1/20 0.42
FEN1 P39748 1/20 0.41
PARP1 P09874 1/20 0.41
NPC1 O15118 1/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 2/20 0.39
JAK2 O60674 1/20 0.39
TYK2 P29597 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
CYP3A4 P08684 1/20 0.39
HTR1A P08908 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL320037 0.86 ALDH1A1 (0.61) ALDH1A1JAK1TSHRPBRM1POLB
SCHEMBL29008206 0.84 ALDH1A1 (0.58) ALDH1A1JAK1TSHRPBRM1POLB
SCHEMBL1613338 0.84 MMP2 (0.43) ALDH1A1JAK1TSHRPOLBPARP1
SCHEMBL147437 0.83 ALDH1A1 (0.52) ALDH1A1JAK1TSHRNR4A2P2RX7
SCHEMBL19972032 0.83 ALDH1A1 (0.71) ALDH1A1JAK1TSHRNR4A2P2RX7
SCHEMBL1188823 0.81 ALDH1A1 (0.50) ALDH1A1JAK1TSHRNR4A2P2RX7
Hydrochloric Acid SCHEMBL8993445 0.81 ALDH1A1 (0.50) ALDH1A1JAK1TSHRNR4A2P2RX7
SCHEMBL24743503 0.78 TSHR (0.46) ALDH1A1JAK1TSHRNR4A2P2RX7
SCHEMBL1135187 0.78 ALDH1A1 (0.52) ALDH1A1TSHRPBRM1PARP1NPC1
SCHEMBL17329160 0.78 ALDH1A1 (0.52) ALDH1A1TSHRPBRM1POLBFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408454-B1 NOVEL ANTI-INFLAMMATORY AGENTS RESVERLOGIX CORP (CA) 2024-07-24 EP disclosed
US-20240190828-A1 Small Molecule Inhibitors of PBRM1-BD2 NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-06-13 US disclosed
CN-117964560-A Method for constructing quinazolinone derivative through oxidization 淮阴工学院 2024-05-03 CN disclosed
CN-117736192-A PI3K/HDAC dual inhibitor and application thereof 安徽中医药大学 2024-03-22 CN disclosed
EP-4291195-A1 SMALL MOLECULE INHIBITORS OF PBRM1-BD2 The Medical College of Wisconsin, Inc. (US) 2023-12-20 EP disclosed
CN-107252429-B Novel anti-inflammatory agent 雷斯韦洛吉克斯公司 2023-06-16 CN disclosed
WO-2022174085-A1 SMALL MOLECULE INHIBITORS OF PBRM1-BD2 THE MEDICAL COLLEGE OF WISCONSIN, INC. (US) 2022-08-18 WO disclosed
WO-2022174085-A1 SMALL MOLECULE INHIBITORS OF PBRM1-BD2 THE MEDICAL COLLEGE OF WISCONSIN, INC. (US) 2022-08-18 WO disclosed
US-11407719-B2 Anti-inflammatory agents RESVERLOGIX CORP. (CA) 2022-08-09 US disclosed
US-20210070716-A1 ANTI-INFLAMMATORY AGENTS HEPALINK (HONG KONG) LIMITED (HK) 2021-03-11 US disclosed
US-4307113-A TREATMENT OF DIABETES SANDOZ, INC. (US) 1981-12-22 US disclosed
US-4191840-A Oxamic acid derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 1980-03-04 US disclosed
US-4160100-A OXAMIC ACID DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 1979-07-03 US disclosed
US-4154961-A Oxamic acid derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 1979-05-15 US disclosed
US-4069343-A OXAMIC ACID DERIVATIVES FOR THE PREVENTION OF IMMEDIATE TYPE HYPERSENSITIVITY REACTIONS AMERICAN HOME PRODUCTS CORPORATION (US) 1978-01-17 US disclosed
US-4054666-A Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 1977-10-18 US disclosed
US-4054661-A Pyridyl oxamic acid derivatives and use in the prevention of allergic reactions AMERICAN HOME PRODUCTS CORPORATION (US) 1977-10-18 US disclosed
US-4054657-A Pyrimidinyl oxamic acids and esters, and compositions and methods for the suppression of allergic manifestations AMERICAN HOME PRODUCTS CORPORATION (US) 1977-10-18 US disclosed
US-4036837-A 2 Alkoxyoxamoyl-pyrazines AMERICAN HOME PRODUCTS CORPORATION (US) 1977-07-19 US disclosed
US-3966965-A Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions AMERICAN HOME PRODUCTS CORPORATION (US) 1976-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11407719-B2 Anti-inflammatory agents VCAM1, ICAM1, IL6 ALDH1A1 587/4885JAK1 706/4885TSHR 4418/4885
US-20210070716-A1 ANTI-INFLAMMATORY AGENTS VCAM1, ICAM1, IL6 ALDH1A1 587/4885JAK1 706/4885TSHR 4418/4885
US-20240190828-A1 Small Molecule Inhibitors of PBRM1-BD2 BRD2, PBRM1, BRDT ALDH1A1 4514/4885JAK1 3220/4885TSHR 4143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.